Posts Tagged ‘BBC’
More Misguided Expenditure From The Monkeys At The BBC.
The BBC can mount a year-long investigation into the trade in baby chimpanzees and drown us all in heartbreaking, sentimental images for days on end.
But when it comes to the hundreds of thousands of people who live in pain, suffering and disability in the UK, in constant fear of a knock at the door because they use medicinal cannabis, the BBC are just stooges and slaves to government misinformation.
The only time the BBC covers the medicinal cannabis issue is when it’s forced to by proceedings in Parliament or when its promoting the work of cannabis oil scammers and rip off artists as it has done on BBC3 recently.
One properly funded documentary, interviewing patients, scientists, doctors and people involved in the genuine campaign could force our government to change its wicked and cruel policy. That wouldn’t suit the BBC’s paymasters though would it? They’re the same people as enforce the evil policy in the first place.
Theresa May Is Not A Tory, She’s An Authoritarian Bureaucrat.
LONDON, ENGLAND – JANUARY 17: British Prime Minister Theresa May delivers her keynote speech on Brexit at Lancaster House on January 17, 2017.
At the beginning of last week, Tuesday, 17th January, Theresa May finally made clear that leaving the EU means leaving the single market. It also means leaving the customs union because without doing so it will be impossible to negotiate independent trade agreements.
This has been obvious all along. Before the referendum, campaigners on both sides were clear. The idea that there was any doubt about it was an invention of the soft-left Blairites at the BBC, eagerly supported by the delusional Tim Farron and his party, now the most illiberal, anti-democratic party in Britain.
I’m unhappy that Ms May didn’t make this clarification a lot sooner but of course she was a Remainer and as David Cameron said, it would be foolish to have a captain to steer the ship in a direction he or she didn’t want to go.
I am generally very unhappy about Ms May’s style of government. It is secretive, authoritarian, dismissive of public opinion and everything is played very close to her chest and as much behind closed doors as she can get away with. Her dictatorial, micro-managerial style at the Home Office is continuing in her role as PM and I believe it is unsustainable for the leader of our country. We need far more openness, interest in the people and a desire to inform rather than to conceal.
But the shocker for me was her repudiation of central Conservative philosophy. She derided the ‘cult of individualism’ as she put it.
Ms May, the Tory Party is all about the individual. It is about individual liberty and individual responsibility. Individualism is the very essence of why I am a Tory.
Then today the brazen cover up about the Trident missile launch which was kept secret from Parliament, even as it was debating the renewal of our nuclear deterrent. Her secretive, fundamentally dishonest approach was revealed as she dodged Andrew Marr’s questions again and again. It is obvious that she did know about the incident, chose to keep it secret from both Parliament and the electorate and refused to be honest about it when questioned.
I am , of course, reminded about her attempt to falsify and cover up the International Comparators report on drugs policy which showed clearly that harsher criminal sanctions have no affect at all on drugs use. This didn’t fit with her prohibitionist prejudice and she wanted it changed to deceive Parliament and the electorate.
I have given Theresa May a more than adequate, even generous, chance to prove herself, particularly given my knowledge of her conduct as Home Secretary. She was the right compromise candidate at the time but now the Conservative Party needs to get rid of her and appoint someone with leadership ability. I was impressed with her initial words about inclusiveness and a country that ‘works for everyone’ but I see now that the leopard has not changed its spots. She is authoritarian, illiberal, secretive, anti-democratic and, most importantly, dishonest.
Theresa May is no Tory and she is not fit to be prime minister.
CLEAR’s Submission To The Parliamentary Inquiry Into Medicinal Cannabis
This was the response that CLEAR submitted to the APPG in February 2016. In March 2016, Roland Gyallay-Pap, then managing director of CLEAR and Peter Reynolds, president, were called to give oral evidence to the Inquiry.
A PDF copy of this document may be downloaded here.
Introduction
In June 2015 the All-Party Parliamentary Group for Drug Policy Reform (APPG) published a short report arguing for a rescheduling of cannabis to make it more widely available for medical use. Following the publication of that report there are a number of key questions remaining that it would like to address by means of a Short Inquiry.
CLEAR Cannabis Law Reform has been asked to submit evidence to the Inquiry in answer to these specific questions:
- Whether switching the medical status of cannabis from schedule 1 to a less restrictive schedule would be beneficial?
- What do you understand to be the range and extent of unofficial use of cannabis for medical purposes?
- What has been the impact of the current schedule 1 status on research into the medicinal uses of cannabis?
- Is there useful evidence emerging from the regulation of cannabis in over 20 US states and elsewhere and what does it tell us about the case for cannabis to be included in the UK pharmacopeia?
- What would be the implications of licencing cannabis for medicinal use following a change in Schedule?
- What role could EU regulations play in developing the potential for the medicinal use of cannabis?
We have also added a further response with additional information.
- Access to prescribed Bedrocan medicinal cannabis is already possible based on careful use of loopholes and errors in existing English law.
Whether switching the medical status of cannabis from schedule 1 to a less restrictive schedule would be beneficial?
Yes, we consider that switching cannabis from schedule 1 to a less restrictive schedule would be beneficial, both so that it could be prescribed by doctors as medicine and so that it could more easily be used in research into its use and effects.
Cannabis has been in schedule 1 of the Misuse of Drugs Regulations1 (MoDR) since the Misuse of Drugs Act 19712 (MoDA) came into force. Drugs in schedule 1 are specified as having no medicinal value. However, an inquiry by the House of Lords Science and Technology Committee published in 19983 recommended that doctors should be permitted to prescribe cannabis and that it should be moved to schedule 2. Strangely the government’s response to this recommendation was further to tighten restrictions by the Misuse of Drugs (Designation) Order 20014, which designates cannabis under section 7(4) of MoDA so that it is unlawful “for a doctor, dentist, veterinary practitioner or veterinary surgeon, acting in his capacity as such, to prescribe, administer, manufacture, compound or supply” it.
In fact, cannabis has already been re-scheduled into schedule 4 under the international non-proprietary name of nabiximols (Sativex)5. Although this is specified as being an extract of THC and CBD, it is clear from statements by the manufacturing company, GW Pharmaceuticals, that nabiximols is whole plant cannabis. Dr Geoffrey Guy, founder and chairman of GW, is on the record:
“Most people in our industry said it was impossible to turn cannabis into a prescription medicine. We had to rewrite the rule book. We have the first approval of a plant extract drug in modern history. It has 420 molecules, whereas every other drug has just one.”6
GW pharmaceuticals has confirmed that this quotation is accurate.7
The MHRA has chosen to issue a marketing authorisation8 for nabiximols (Sativex) by regarding it as only a two molecule medicine. The marketing authorisation is therefore at best inaccurate, at worst dishonest.
What do you understand to be the range and extent of unofficial use of cannabis for medical purposes?
In 2011, CLEAR commissioned independent, expert research from the Independent Drug Monitoring Unit (IDMU). The report, ‘Taxing the UK Cannabis Market’9, reveals there are three million people using cannabis in the UK regularly (at least once per month). Since then CLEAR has regularly polled its members and followers and consistently one in three of respondents claim at least some part of their use is for medicinal reasons. It is reasonable to estimate therefore that there are up to one million people using cannabis for medicinal purposes in the UK. It is certain that there are hundreds of thousands of medicinal users and previous estimates in the region of 30,000 are far too low.
The most common indications for medicinal use declared by our respondents are chronic pain, fibromyalgia, Crohn’s disease, multiple sclerosis and cancer.
Our interpretation of the responses we have received is that generally cannabis is used as a palliative agent. Some people find it so effective that they consider it to be a ‘cure’ as long as they keep using it. Others find it extremely helpful in reducing the amount of toxic and/or dangerous pharmaceutical medicines they are prescribed. Often the side effects of pharmaceutical medicines are severe and debilitating and cannabis offers a way of minimising these.
CLEAR maintains a Medicinal Users Panel10 which members join in order to gain support in lobbying their MPs and/or attempting to obtain prescribed Bedrocan medicinal cannabis. The active membership of the panel varies between 20 to 80 people. Panel members have also been involved in delegations to meet government ministers and other parliamentarians
What has been the impact of the current schedule 1 status on research into the medicinal uses of cannabis?
In the UK there is very little research into the medicinal uses of cannabis, except that undertaken by GW Pharmaceuticals11. There has been some research carried out into single cannabinoids but the evidence is that the therapeutic effects of cannabis depend on the whole plant ‘entourage effect’.
The allopathic, reductionist approach to medicine, which is reflected in the way that the MHRA regulates medicines, is the fundamental, establishment doctrine that impedes research into cannabis.
Sadly, one of the biggest trials of MS patients, the CUPID study at the University of Plymouth12, intended to look at the many anecdotal reports of benefit, used synthetic THC and consequently the results were disappointing and irrelevant to the claims it sought to test.
It is far easier to obtain funding for research into the harms of cannabis which is undertaken with an almost absurd degree of repetition, most notably by the Institute of Psychiatry at King’s College London (IOPPN).13 It is also worth noting that IOPPN regularly and consistently overstates the results of its research, encouraging the media to report causal effects between cannabis use and mental illness which its research does not support.14
There is a huge stigma around cannabis, largely due to inaccurate, misleading and hysterical press coverage. For instance, neither of the pre-eminent MS patient groups, the MS Society and the MS Trust, will take a stand in support of patients, despite the fact that many use cannabis. Similarly, despite extraordinary human clinical trial results on Crohn’s disease, none of the Crohn’s patient groups will engage with the campaign. Mention cannabis and calls are not returned, people are scared by the stigma. The immediate reaction from all such patient groups is to overlook evidence of benefit and refer to risks to mental health which, in fact, are very low compared to pharmaceutical products. The press, unchallenged by politicians in its disproportionate attention to these risks, bears a heavy responsibility for this stigma and the lack of research.
Unlike many within the reform movement, CLEAR recognises and values the expertise and achievements of GW Pharmaceuticals. However, any doctor or scientist that expresses any interest in medicinal cannabis in the UK is immediately retained or contracted by GW. We receive hundreds of reports of doctors, GPs and consultants, who tacitly and sometimes explicitly support their patients’ use of cannabis but it is impossible to find any doctor who is prepared to speak out publicly. In the few instances where doctors have spoken out on behalf of patients, they have been contacted by Home Office officials and warned. One GP reported that he felt “intimidated”. By contrast, there are tens of thousands of doctors across Europe, Israel and North America who advocate for the use of medicinal cannabis and further research into its applications.
The security and record-keeping requirements for cannabis as a schedule 1 drug15 are wildly disproportionate to the real potential for harm, requiring a high security safe for storage and an audit trail fit for Fort Knox.
In addition the fee for a high THC licence is currently £4700.00 per annum and applications can take more than a year to process. These requirements, delays and corresponding costs severely impede research into medicinal cannabis.
Recently, in response to two government e-petitions, the Home Office issued the following statement:
“In 2013 the Home Office undertook a scoping exercise targeted at a cross-section of the scientific community, including the main research bodies, in response to concerns from a limited number of research professionals that Schedule 1 status was generally impeding research into new drugs.
Our analysis of the responses confirmed a high level of interest, both generally and at institution level, in Schedule 1 research. However, the responses did not support the view that Schedule 1 controlled drug status impedes research in this area. While the responses confirmed Home Office licensing costs and requirements form part of a number of issues which influence decisions to undertake research in this area, ethics approval was identified as the key consideration, while the next most important consideration was the availability of funding.”
We consider this response to be disingenuous and misleading. Cannabis is a special case. It is a combination of hundreds of molecules, unlike other schedule 1 drugs, most of which are single molecules. Also, as is well established in written and archaeological evidence, cannabis has been used effectively for at least 5,000 years as medicine without any evidence of harm.
Furthermore. ethical approval and funding are difficult largely due to the evidence-free scaremongering about cannabis and the consequential stigma, in which the Home Office plays a leading role. Ethical approval and funding do not seem to be a problem in researching potential harms of cannabis. Indeed, as noted above, there is a massive amount of such research even though much of it is repetitive and inconclusive.
Until it is recognised that for many years, under successive governments, the Home Office has been systematically misleading and scaremongering about cannabis, it is difficult to see how an evidence-based decision can be reached. The Home Office regularly makes assertions about cannabis that are completely without evidential support. There is an established prejudice and determination to misinform and this must be tackled at root as it amounts to misconduct and corruption.
Is there useful evidence emerging from the regulation of cannabis in over 20 US states and elsewhere and what does it tell us about the case for cannabis to be included in the UK pharmacopeia?
There is a vast amount of peer-reviewed, published evidence of the safety and efficacy of cannabis as medicine. Much of this arises from research carried out in the USA, the Netherlands and Israel, where medicinal cannabis regulation has been in place for many years.
It is a populist myth, promoted by the Home Office, the press, the BBC and the prohibitionist lobby, that there is no evidence supporting the use of cannabis as medicine.
In February 2015, a delegation of medicinal cannabis users from CLEAR met with George Freeman MP, the life sciences minister, at the Department of Health who is largely responsible for medicines regulation. At the conclusion of the meeting, Mr Freeman requested CLEAR to produce a summary of the available evidence.
The result is the paper ‘Medicinal Cannabis:The Evidence’16 (MCTE) which has received international acclaim, so much so that in association with Centro de Investigaciones del Cannabis (CIC), a Colombian non profit association, a Spanish language version has been published.
MCTE was submitted to George Freeman MP in April 2015. Since then he has repeatedly refused to meet CLEAR again or respond to us directly, even after multiple requests from individual MPs representing CLEAR members. His only responses, received through third parties, fail to address the evidence at all. He simply refers to the legal status of cannabis, the theoretical availability of Sativex and the MHRA process for issuing marketing authorisations in respect of medicines.
This refusal to engage, acknowledge or properly consider the very large amount of evidence that is available is indicative of an inexplicable prejudice within government. Although conspiracy theories abound, it is difficult to understand why ministers adopt this position.
Cannabis was one of the most used medicines in the British pharmacopeia until only about 100 years ago. It could be restored immediately by a stroke of the Home Secretary’s pen to remove it from schedule 1. This would immediately make it possible for doctors to prescribe medicinal cannabis from Bedrocan17, the Netherlands government’s exclusive contractor.
Bedrocan cannabis is carefully regulated by the Netherlands government’s Office of Medicinal Cannabis. It is available in five different THC:CBD ratios. It is already exported to many countries in Europe and the company has established itself in Canada as well. It is less than a tenth the cost of Sativex for equivalent cannabinoid content and can be consumed either by a medical vapouriser or as an infusion.
No minister in this or any previous government has ever presented a coherent reason for the refusal to allow cannabis to be used as a medicine. Their only response is to fall back on largely spurious or exaggerated claims about the harms of recreational use.
What would be the implications of licencing cannabis for medicinal use following a change in Schedule?
Cannabis would not need to be ‘licenced’ for medicinal use following a change in schedule. As soon as it removed from schedule 1, doctors would be able to prescribe it and businesses interested to grow, process and develop cannabis medicines would be able to obtain cultivation/possession licences from the Home Office.
Medicines are no longer ‘licenced’ in the UK. The MHRA grants marketing authorisations. The initial fee, simply for filling in the application form is £103,000.00, thus prohibiting any but the very largest, established businesses from even considering such a venture. The very term ‘marketing authorisation’ reveals the mindset of medicines regulators which is now more about commercial interests than the evaluation of the safety and efficacy of medicines.
The MHRA does have a regulatory scheme for ‘Traditional Herbal Registration’ (THR) but it only applies “if the medicine is used for minor health conditions where medical supervision is not required.”. An application for a THR for cannabis could not be made while it remains in schedule 1 but, if granted, would not permit its use for many conditions where there is excellent evidence of its efficacy.
The MHRA is locked in an inflexible, unscientific and restrictive process which can only evaluate medicines which are either one or two molecules. Its process is designed for synthetic, potentially very dangerous molecules and is entirely unsuitable for a plant based medicine such as cannabis. This is why, as explained above, Sativex has been improperly regulated as containing only two molecules: THC and CBD.
When the Sativex (nabiximols) patent expires, independent analysis of the medicine would certainly demonstrate that it is whole plant cannabis oil. Presumably alternative and/or generic versions could then be produced. However, by any standards, for all parties, the regulation and scheduling of Sativex is inaccurate, if not dishonest, and needs revision.
If cannabis is removed from schedule 1, most appropriately to schedule 4 alongside Sativex, in our judgement there will be a large number of businesses applying for cultivation/possession licences for research which will eventually result in applications for marketing authorisations. In the meantime, it can only be described as cruel and evidence-free not to permit doctors to prescribe Bedrocan, a safe, effective medicine already regulated by another European government.
It is likely that enabling the prescription of Bedrocan would result in substantial savings to the NHS medicines budget. However, any idea that this could be quantified based on existing evidence is fanciful. Certainly, compared to existing prescription medicines and Sativex, Bedrocan is very inexpensive, probably less than 10 euros per patient per day. However, the complexity of calculating which medicines it could replace by individual, partly or wholly and for how long makes the exercise so hypothetical as to be meaningless.
It must be true that once local, UK-based cultivation of medicinal cannabis was permitted, prices would reduce even further.
What role could EU regulations play in developing the potential for the medicinal use of cannabis?
Aside from France and Ireland (which is moving rapidly towards drugs policy reform), every other EU country has a more intelligent, compassionate and evidence-based policy towards medicinal cannabis. Based on existing policy and its record, the UK government would simply refuse to comply with any EU regulation of medicinal cannabis.
Under the Schengen Acquis (of which UK is a signatory, though not to the full Schengen Agreement), if a medicine is prescribed to a resident of a member state, that resident may travel to other member states with up to three month’s supply under the protection of a Schengen certificate. The effect of this is that a resident of the Netherlands, Belgium, Finland, Germany, Italy, etc. can bring prescribed cannabis, likely Bedrocan, into the UK and use it without restriction.
The crucial test here is residency, so it is not possible for a UK resident to travel to another country, obtain a prescription and then return to the UK legally with cannabis. Presently, a Schengen certificate for a UK resident has to be issued by the Home Office. Strangely and in contravention of this explicit provision, Norway (Non EU but a signatory to Schengen) does permit its residents to obtain prescriptions, usually in the Netherlands, and return home with cannabis.
It is also likely that given the hostility towards EU regulation, adding cannabis into that debate would be counterproductive. It would be used as another stick with which to beat the EU.
Access to prescribed Bedrocan medicinal cannabis is already possible based on careful use of loopholes and errors in existing English law.
As some members of the APPG are aware, CLEAR has been involved in trying to obtain legal access to prescribed Bedrocan since 2012. We now have approximately a dozen members who regularly receive private prescriptions from their doctors (both consultants and GPs) and travel to the Netherlands to have them dispensed.
In all instances, these individuals have either declared their medicine at customs and/or have made prior arrangements with the Border Force, producing supporting documentation.
This is possible because of errors and inconsistencies in the MoDA and the MoDR. All English drugs legislation, including the recent Psychoactive Substances Act 2016, is badly drafted, contradictory and scientifically illiterate.
The principle active ingredients of cannabis are delta-9-THC and cannabidiol (CBD). Bedrocan products are specified with different ratios of these substances. While cannabis is classified in schedule 1, so is delta-9-THC but it is also in schedule 2 described as dronabinol, which is the international non-proprietary name (INN) for delta-9-THC. CBD is not a controlled drug.
Therefore, if a doctor is prepared to write a prescription e.g. dronabinol (Bedrocan 22%) or dronabinol (Bediol 7.5%), three month’s supply of the medicine may be legitimately imported as a schedule 2 drug.
In the past four years only one CLEAR member has been frustrated in this. He had his medicine seized but he was not prosecuted. An appeal against the seizure failed.
Clearly, the vital factor in this scheme is a doctor who understands the law and the science and is prepared to write the prescription.
References
1. Misuse of Drugs Regulations 2001 http://www.legislation.gov.uk/uksi/2001/3998/contents/made
2. Misuse of Drugs Act 1971 http://www.legislation.gov.uk/ukpga/1971/38/contents
3. House of Lords Science and Technology Committee report 1998 http://www.parliament.the-stationery-office.co.uk/pa/ld199798/ldselect/ldsctech/151/15101.htm
4. Misuse of Drugs (Designation) Order 2001 http://www.legislation.gov.uk/uksi/2001/3997/made
5. Nabiximols (Sativex) https://en.wikipedia.org/wiki/Nabiximols
6. Cambridge News, 24th Jan 2012 http://www.cambridge-news.co.uk/Cannabis-company-enjoys-major-growth/story-22509041-detail/story.html
7. Email corres with Marc Rogerson, GW Pharma, 160312. Attached.
8. Sativex (nabiximols) marketing authorisation, MHRA , 2010 http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con084961.pdf
9. Taxing the UK Cannabis Market, IDMU, 2011 http://clear-uk.org/media/uploads/2011/09/TaxUKCan.pdf
10. CLEAR Medicinal Users Panel http://clear-uk.org/pages/medicinal-panel/
11. GW Pharmaceuticals website http://www.gwpharm.com/
12. CUPID study, University of Plymouth, 2015 http://www.ncbi.nlm.nih.gov/pubmed/25676540
13. Institute of Psychiatry at King’s College London website http://www.kcl.ac.uk/ioppn/index.aspx
14. King’s College Confirms Institute of Psychiatry Misled Media On Cannabis Brain Study. CLEAR, 2015 http://clear-uk.org/kings-college-confirms-institute-of-psychiatry-misled-media-on-cannabis-brain-study/
15. Controlled Drugs (Supervision of management and use) Regulations 2013, Dept of Health https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/214915/15-02-2013-controlled-drugs-regulation-information.pdf
16. Medicinal Cannabis: the Evidence, CLEAR, 2015 http://clear-uk.org/static/media/PDFs/medicinal_cannabis_the_evidence.pdf Attached
17. Bedrocan BV website http://www.bedrocan.nl/
Chip Somers, Drug Therapist Charlatan. Ignorant? A Liar? Or Both?
It takes a lot to get me angry these days about attitudes towards cannabis. Many people are simply misinformed and are themselves victims of a relentless propaganda campaign by governments and the gutter press. Today though I watched the Victoria Derbyshire show on catch up from last Tuesday, the day that Parliament published published its report on medicinal cannabis. In the studio were CLEAR member Lara Smith, UPA member Faye Adams and Chip Somers, described as a ‘government advisor’, was on Skype from his home in Hampstead.
You can watch the programme on BBC iPlayer here. The segment runs from 1:22:09 to 1:33.58.
Now this is the BBC, which is always pro status quo and has a dreadful record on inaccurate reporting about cannabis. It’s also the Victoria Derbyshire show, which is a long way from serious news and is more like a cross between Jeremy Kyle and Woman’s Hour – but give them credit for covering the issue
You can’t blame people who have been misinformed and whose prejudice is deeply ingrained from years of brainwashing. This applies to many MPs, journalists, even doctors and scientists. Remember, the endocannabinoid system. one of the most important physiological systems, isn’t even taught in UK medical schools, so ignorance is widespread, even amongst those you would expect to be well informed.
Chip Somers
There can be no excuse for this mendacious and wicked man, Chip Somers, though. He is, you will remember, the addiction therapist who grandstanded over his work with Russell Brand a couple of years ago. He advocates the total abstinence route to recovery which has been so eagerly embraced by the judgmental puritans at the Home Office and has led directly to the highest ever rate of drug overdose deaths, only released last week. Is the man simply a complete fool or is he deliberately dishonest? I think it has to be both. No one with the experience he claims could be so stupid. For some reason: misplaced morality, corrupt influence of money, government pressure, self-promotion of his therapy business – he is engaged in deception.
I’m not going to analyse every one of his miserable words. Watch him for yourself but prepare to be appalled. Suffice to say that his only tactic was to argue against medicinal use with ‘dangers’ that apply only to recreational use by children – a transparent disinformation strategy. He was also nothing less than abusive to Faye’s and Lara’s testimony and his dismissal of Professor Mike Barnes’ evidence review, which analyses 20,000 scientific papers, was just laughable.
Chip Somers is a liar, a charlatan, a confidence trickster and a deceiver. If only some such donkey of a faux therapist would seek recourse in the courts for such descriptions of him. Then we would have the opportunity to prove that he is a man of bad character and evil motivation.
The BBC’s ‘Traingate’ Attack On Corbyn Is Both Hypocritical And Unfair.
Every single day of the year, BBC news crews do exactly what Jeremy Corbyn’s video crew did on his train journey the other day. They ‘set up’ a shot to make the point or illustrate the story they want to communicate. When the interviewer nods thoughtfully in response to an interviewee’s wise words, it’s all acting. On a single camera shoot you do the cutaways after the interview and edit them in afterwards. If you can’t get the shot you need at the time you’re there, you set it up for the camera.
There’s nothing new, clever or dishonest about this. What is dishonest is the BBC’s use of it to smear and abuse a man who was just doing his job in exactly the same way as a BBC journalist. Of course the anti-Corbyn Fleet Street Mafia has leapt on it with alacrity, a lot more dishonesty, abuse, exaggeration and bile – but what would you expect from the British press?
Self-Serving Hypocrite
As for Richard Branson, I used to be fan like most of the rest of the country but in the last five years I’ve realised that he is an entirely self-serving, selfish and self-centred individual. Nothing the matter with that either, except that he presents himself as a pious, altruistic and groovy guy who’s down with the common people and on their side. There’s as much truth in that as there is Branson in Branston pickle. It’s rubbish. On drugs policy Branson is grandstanding and nothing else. His loose change from yesterday’s jeans would transform the British cannabis campaign but he’s too mean to come up even with a tenner. Seeing him wade in with the mob beating up Corbyn and kick him two or three times while he’s down is truly sickening.
The far more serious matter though is the BBC’s hypocrisy and dishonesty which must be a breach of its Royal Charter obligations. The BBC is composed of soft-left Blairites with a powerful built-in default to the status quo. While I don’t support any of the multiple, confused versions of the Labour Party, I’m in even less support of corrupt, dishonest conduct by our national broadcaster.
BBC. The Truth About Healthy Eating.
For all you food fad fashionistas, vegans and vegetablists, with your gluten-free, organic, quinoa, tofu, dairy-free and right-on, overpriced naaaturaaal, whole and holy foods, this is the day you got found out!
Only the BBC could do a great programme like this which exposes, gently but unmercifully, the giant confidence trick that is the health food, supplement and superfood business.
It’s all a load of codswallop. You’re being cheated into spending tens of pounds on rip-off products when you can eat healthily for pennies.
Watch it and weep for those have been taken in by the goji berries and coconut oil scam. A pack of butter and an apple is a far better buy.
Fleet Street Celebrates Total Victory Over Leveson. The Public Interest Is ‘Collateral Damage’.
This article started as a comment on an excellent piece in 'The Conversation'
by Professor of Communications, University of Westminster.
Politics versus public interest in battle over press regulation.
The Fleet Street Mafia has successfully subverted and corrupted our political leadership to ensure that Leveson has achieved nothing in bringing the worst excesses of the press under control. In fact, if anything, press regulation is even weaker and less effective than before Lord Justice Leveson first assumed the chair of the inquiry.
The Leveson Inquiry. A Waste Of Time And Public Money.
The whole exercise has been a farce and a waste of public money. Cameron and his cronies are so terrified of the press that they will do literally anything; change any policy, ignore any evidence, promote any untruth, in order to comply with the wishes of Murdoch, the Barclay Brothers or Paul Dacre.
IPSO, the replacement for the PCC, is even more corrupt, dishonest and fraudulent in its practice than its predecessor. It fails to enforce the Editors’ Code and instead finds excuses for publishers to breach the code as it suits them. It acts in expressly the opposite interest to that which it pretends. It seeks to support the interests of the press over the interests of the public at all stages.
IPSO’s new strategy to deal with troublesome and substantive complaints is simply to dismiss them, even without any consideration. The PCC would have made a play of investigating complaints before dismissing them but IPSO simply closes them down saying they do not raise any possible breaches of the code – even when they consist of blatant inaccuracy and distortion.
John Whittingdale MP. Sycophant And Toady To The Press Barons.
The net effect of Leveson is to place the public in a worse position than before it started. We have gone backwards. The press is more powerful, politicians are supine. In the case of weak, corrupt individuals like John Whittingdale, he has become the servant of the press barons, doing their bidding, performing at their wish from inside government where he betrays the electorate and subverts our democracy.
Fleet Street is like the Wild West but with immunity against any consequences of any actions. The only hope that we have is the terminal decline of newspaper circulation and that the power of this unelected elite of editors and proprietors will crumble over time. It would help if our other media, particularly the BBC, would stop letting Fleet Street set the news agenda. We need to accelerate the move to online news content.
The whole corrupt edifice is well illustrated by the regular Sunday morning spectacle of Andrew Marr, a dyed in the wool Fleet Street stooge, interviewing low-rent tabloid hacks such as Amanda Platell or Jane Moore, before another servile chat with a government minister. This defines the shabby, dishonest politicking within and around the Westminster bubble.
We do not have a a ‘free press’, we have an out of control, rampant, vested interest. While we need ‘freedom of the press’, in that journalists may investigate and publish the truth, we also need ‘freedom from the press’ and its bullying, self-serving control of our country and its political system.
